Alzheimer's drug that slows disease gets backing from FDA advisers
The FDA will make the final decision on approval later this year
Source: voanews.com
Eli Lilly Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Eli Lilly Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Eli Lilly Co Today - Breaking & Trending Today
FDA advisory committee backs donanemab for early-stage Alzheimer's
An FDA advisory panel on Monday voted in favor of donanemab as a treatment for early symptomatic Alzheimer’s disease.In a press conference on June 10, the Peripheral and Central Nervous System Drugs Advisory Committee ruled 11-0 that donanemab (Eli Lilly & Co.), a once-per-month, 30-minute infusion treatment, was effective in treating individuals with mild cognitive impairment and mild
Source: healio.com
Alzheimer's could be a 'very big category' for Eli Lilly: Dr Gottlieb
Eli Lilly received backing for its Alzheimer's drug from FDA advisors today. Dr Scott Gottlieb discussed the development on CNBC.
Source: invezz.com
7 Blue-Chip Stocks to Add to Your June Buy List
There are huge advantages to having blue-chip stocks in your portfolio, particularly when the stock market is on a roll. Consider these.
Source: investorplace.com
Targeted psoriatic arthritis therapies demonstrate low risk for serious infection
Serious infections were uncommon among patients with psoriatic arthritis exposed to targeted therapies for the first time in “a large and exhaustive” French cohort, according to data published in RMD Open.Compared with new users of adalimumab (Humira, Abbvie), risk for serious infection was significantly lower among new users of etanercept (Enbrel, Immunex) and ustekinumab (Stelara,
Source: healio.com